Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
Indoles
aryl hydrocarbon receptor
Microbiota
pancreatic cancer
T cells
Tryptophan
microbiome
macrophage
indoles
CD8-Positive T-Lymphocytes
Prognosis
Pancreatic Neoplasms
Mice
Lymphocytes, Tumor-Infiltrating
Receptors, Aryl Hydrocarbon
Tumor-Associated Macrophages
Immune Tolerance
Tumor Microenvironment
tumor microenvironment
Animals
Humans
immunotherapy
immune suppression
metabolism
Carcinoma, Pancreatic Ductal
DOI:
10.1016/j.immuni.2022.01.006
Publication Date:
2022-02-08T15:41:40Z
AUTHORS (30)
ABSTRACT
The aryl hydrocarbon receptor (AhR) is a sensor of products tryptophan metabolism and potent modulator immunity. Here, we examined the impact AhR in tumor-associated macrophage (TAM) function pancreatic ductal adenocarcinoma (PDAC). TAMs exhibited high activity Ahr-deficient macrophages developed an inflammatory phenotype. Deletion Ahr myeloid cells or pharmacologic inhibition reduced PDAC growth, improved efficacy immune checkpoint blockade, increased intra-tumoral frequencies IFNγ+CD8+ T cells. Macrophage was not required for this effect. Rather, dependent on Lactobacillus metabolization dietary to indoles. Removal TAM promoted accumulation TNFα+IFNγ+CD8+ cells; provision indoles blocked In patients with PDAC, AHR expression associated rapid disease progression mortality, as well immune-suppressive phenotype, suggesting conservation regulatory axis human disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (358)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....